108Labs announces the M2 Milk Platform

Conjuring the Magic of Milk, 108Labs announces the M2™ smart bioreactor milk production platform. M2 is a turnkey wetware, software, and hardware milk-making stack driven by artificial intelligence to reduce the cost and accelerate the scaling of cell-cultured milk production worldwide.

Human milk is the most important and least accessible food on earth. Cell-cultured bovine milk may retire cows and slow global warming some day. The mission of 108Labs’ newly organized entities is to accelerate the future of human milk and replacement dairy across many health and food product fields with the M2 platform.

108Labs entities:

Pure Mammary Factors, Inc. was founded in December 2021 and is democratizing cell-cultured milks by making product research and commercialization more affordable and accessible. A Pure™ dairy product is any cell-cultured milk product created with Pure Mammary Factors. Unlike raw milk, Pure mammary cell medium and growth factors produce Pure milks that are safe for human consumption right out of the cell without needing pasteurization.

M2Health, Inc. May was founded in May 2020 and is developing Pure therapeutic human milk for prescription drugs and humanized infant formula products.

M2Foods, Inc. was founded in September 2021 and is developing Pure foods including bovine artisanal cheeses and other replacement dairy food products.

108Labs and 108Labs entities are licensing M2 and collaborating with dairy, food and pharmaceutical partners to accelerate Pure food and health products to market worldwide.

What 108Labs has accomplished as a self-funded, family-run incubator over the last decade is astonishing, but the future is even more amazing and I couldn’t be more excited to work with Shayne and 108Labs on the future of food.” – Scott Matthews, COO, M2Foods.